Nasdaq Net Change Percentage Gainers & Losers

Dow Jones
Mar 07, 2025
GAINERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Kestra Medical TechsKMTS21.844.8428.473,946,652
LendingTreeTREE49.349.0722.521,338,231
WISeKey Intl Hldg ADRWKEY4.790.8421.27591,380
America's Car-MartCRMT44.476.1115.93334,657
Artiva BiotherapeuticsARTV5.100.6113.59103,190
ECARX HoldingsECX2.730.3213.285,811,771
Bioceres Crop SolutionsBIOX4.980.5813.181,084,568
Climb Global SolutionsCLMB134.0015.1912.78138,866
Apogee TherapeuticsAPGE35.444.0112.761,063,354
GrShr 2x Sh NVDA DailyNVD34.933.6911.814,402,046
LOSERS
COMPANYSYMBOLLASTCHANGEPERCENTVOLUME
------------------------------------
Sleep NumberSNBR7.49-5.40-41.894,546,266
SBC Medical Group HldgsSBC3.09-1.51-32.85164,698
CareCloudCCLD2.11-1.01-32.371,194,687
MongoDBMDB192.98-71.15-26.9414,183,273
Rapport TherapeuticsRAPP8.08-2.39-22.83486,196
GrShr 2x Long PLTR DailyPTIR127.17-34.92-21.541,343,361
Direxion Dly PLTR Bull 2XPLTU26.95-7.34-21.414,528,629
Intuitive Machines Cl ALUNR11.26-2.85-20.2047,020,767
Marvell TechnologyMRVL72.28-17.86-19.8160,733,629
Silvaco GroupSVCO4.91-1.20-19.64653,069
Only includes stocks with a prior day close of $2 a share
or higher and at least 2,000 shares traded today.
Data are delayed at least 15 minutes.
Source: WSJ Market Data Group

(END) Dow Jones Newswires

March 06, 2025 17:42 ET (22:42 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10